Skip to main content
. 2007 Dec 4;98(1):91–97. doi: 10.1038/sj.bjc.6604101

Figure 2.

Figure 2

Assessment of inflammation in mice bearing tumour xenografts. Mice (n=4–5 per group) were injected with (vehicle) control or breast E0771, melanoma B16 or EHS sarcoma xenografts as described in Materials and Methods. (A) Relative quantification of hepatic acute phase protein, Sap, in tumour-bearing and control mice. Hepatic Sap mRNA levels were determined by Q-PCR and normalised to 18S RNA expression. (B) Serum concentration of IL-6 in tumour-bearing and control mice. Sera were analysed for IL-6 concentrations by ELISA. Box and whisker plot, median and interquartile range. *P<0.05; **P<0.001.